The Actions and Mechanisms of P2X7R and p38 MAPK Activation in Mediating Bortezomib‐Induced Neuropathic Pain
Open Access
- 1 January 2020
- journal article
- research article
- Published by Wiley in BioMed Research International
- Vol. 2020 (1) , 8143754
Abstract
The proteasome inhibitor bortezomib (BTZ) is a potent first‐line anticancer drug for multiple myeloma; nonetheless, it induced peripheral neuropathy. It has been suggested that many cytokines may play a role in mediating neuropathic pain, but the underlying molecular mechanism is not fully understood. Recent studies have shown that neuropathic pain is closely related to the purinergic ligand‐gated ion channel 7 receptor (P2X7R), one of the P2X receptors, which is richly expressed in glial cells. P2X7‐p38 pathway is correlated with microglia‐ and satellite glial cell‐ (SGC‐) mediated neuropathic pain. However, the association of P2X7R and p38MAPK in mediating BTZ‐induced neuropathic pain remains unclear. In this study, the relationship between P2X7R activation and p38 phosphorylation in the dorsal root ganglion (DRG) and spinal dorsal horn (SDH) in the development and maintenance of BTZ‐induced neuropathic pain was elucidated. The results showed that BTZ increased mechanical thresholds in rats, accompanied with upregulation of P2X7R expression and p38MAPK phosphorylation, indicating that P2X7R and p38MAPK are key molecules in the development and maintenance of BTZ‐induced neuropathic pain. Inhibiting p38MAPK phosphorylation with SB203580 resulted in downregulation of P2X7R expression levels. Inhibition of P2X7R with Brilliant Blue G (BBG) reversed neuropathic pain might decrease through the expression of tumor necrosis factor‐α (TNF‐α), interleukin‐1β (IL‐1β), and IL‐6 via inhibiting p38MAPK phosphorylation. The P2X7R/p38MAPK signaling pathway in SGCs of DRG and microglia of SDH might be a potential pharmacological target behind this mechanism as an opportunity to relieve BTZ‐induced neuropathic pain.Keywords
Funding Information
- Shandong Provincial Key Research and Development Project (2019GSF107062)
This publication has 50 references indexed in Scilit:
- The protective effect of resveratrol in the transmission of neuropathic pain mediated by the P2X7 receptor in the dorsal root gangliaNeurochemistry International, 2017
- RETRACTED: Inhibition of the p38-MAPK signaling pathway suppresses the apoptosis and expression of proinflammatory cytokines in human osteoarthritis chondrocytesCytokine, 2017
- Microvesicles shed from microglia activated by the P2X7-p38 pathway are involved in neuropathic pain induced by spinal nerve ligation in ratsPurinergic Signalling, 2016
- The possible involvement of JNK activation in the spinal dorsal horn in bortezomib-induced allodynia: the role of TNF-α and IL-1βJournal of Anesthesia, 2015
- Over-expression of P2X7 receptors in spinal glial cells contributes to the development of chronic postsurgical pain induced by skin/muscle incision and retraction (SMIR) in ratsExperimental Neurology, 2014
- The effects of galanin on neuropathic pain in streptozotocin-induced diabetic ratsEuropean Journal of Pharmacology, 2012
- The role of dorsal root ganglia activation and brain‐derived neurotrophic factor in multiple sclerosisJournal of Cellular and Molecular Medicine, 2011
- P2X7 receptor-deficient mice are susceptible to bone cancer painPain, 2011
- BDNF in sensory neurons and chronic painNeuroscience Research, 2006
- A new mathematical model for relative quantification in real-time RT-PCRNucleic Acids Research, 2001